These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37864287)

  • 1. Benchmarking TriadAb using targets from the second antibody modeling assessment.
    Lee FS; Anderson AG; Olafson BD
    Protein Eng Des Sel; 2023 Jan; 36():. PubMed ID: 37864287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution modeling of antibody structures by a combination of bioinformatics, expert knowledge, and molecular simulations.
    Shirai H; Ikeda K; Yamashita K; Tsuchiya Y; Sarmiento J; Liang S; Morokata T; Mizuguchi K; Higo J; Standley DM; Nakamura H
    Proteins; 2014 Aug; 82(8):1624-35. PubMed ID: 24756852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody structure determination using a combination of homology modeling, energy-based refinement, and loop prediction.
    Zhu K; Day T; Warshaviak D; Murrett C; Friesner R; Pearlman D
    Proteins; 2014 Aug; 82(8):1646-55. PubMed ID: 24619874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of fully automated antibody homology modeling protocols in molecular operating environment.
    Maier JK; Labute P
    Proteins; 2014 Aug; 82(8):1599-610. PubMed ID: 24715627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homology Modeling of Antibody Variable Regions: Methods and Applications.
    Bansia H; Ramakumar S
    Methods Mol Biol; 2023; 2627():301-319. PubMed ID: 36959454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated antibody structure prediction using Accelrys tools: results and best practices.
    Fasnacht M; Butenhof K; Goupil-Lamy A; Hernandez-Guzman F; Huang H; Yan L
    Proteins; 2014 Aug; 82(8):1583-98. PubMed ID: 24833271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody modeling assessment.
    Almagro JC; Beavers MP; Hernandez-Guzman F; Maier J; Shaulsky J; Butenhof K; Labute P; Thorsteinson N; Kelly K; Teplyakov A; Luo J; Sweet R; Gilliland GL
    Proteins; 2011 Nov; 79(11):3050-66. PubMed ID: 21935986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer-assisted modeling of antibody variable domains.
    Ramos OH
    Methods Mol Biol; 2012; 907():39-55. PubMed ID: 22907344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis and modeling of the variable region of camelid single-domain antibodies.
    Sircar A; Sanni KA; Shi J; Gray JJ
    J Immunol; 2011 Jun; 186(11):6357-67. PubMed ID: 21525384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new clustering of antibody CDR loop conformations.
    North B; Lehmann A; Dunbrack RL
    J Mol Biol; 2011 Feb; 406(2):228-56. PubMed ID: 21035459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MoFvAb: Modeling the Fv region of antibodies.
    Bujotzek A; Fuchs A; Qu C; Benz J; Klostermann S; Antes I; Georges G
    MAbs; 2015; 7(5):838-52. PubMed ID: 26176812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody modeling assessment II. Structures and models.
    Teplyakov A; Luo J; Obmolova G; Malia TJ; Sweet R; Stanfield RL; Kodangattil S; Almagro JC; Gilliland GL
    Proteins; 2014 Aug; 82(8):1563-82. PubMed ID: 24633955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in human IgG1 and IgG4 S228P monoclonal antibodies viscosity and self-interactions: Experimental assessment and computational predictions of domain interactions.
    Lai PK; Ghag G; Yu Y; Juan V; Fayadat-Dilman L; Trout BL
    MAbs; 2021; 13(1):1991256. PubMed ID: 34747330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canonical structures of short CDR-L3 in antibodies.
    Teplyakov A; Gilliland GL
    Proteins; 2014 Aug; 82(8):1668-73. PubMed ID: 24623659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting antibody complementarity determining region structures without classification.
    Choi Y; Deane CM
    Mol Biosyst; 2011 Dec; 7(12):3327-34. PubMed ID: 22011953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated Aufbau of antibody structures from given sequences using Macromoltek's SmrtMolAntibody.
    Berrondo M; Kaufmann S; Berrondo M
    Proteins; 2014 Aug; 82(8):1636-45. PubMed ID: 24777752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactibodies generated by kinetic selection couple chemical reactivity with favorable protein dynamics.
    Smirnov I; Carletti E; Kurkova I; Nachon F; Nicolet Y; Mitkevich VA; Débat H; Avalle B; Belogurov AA; Kuznetsov N; Reshetnyak A; Masson P; Tonevitsky AG; Ponomarenko N; Makarov AA; Friboulet A; Tramontano A; Gabibov A
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15954-9. PubMed ID: 21896761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of 5518 unique, productively rearranged human VH3-23*01 gene sequences reveals CDR-H3 length-dependent usage of the IGHD2 gene family.
    Chen L; Duan Y; Benatuil L; Stine WB
    Protein Eng Des Sel; 2017 Sep; 30(9):603-609. PubMed ID: 28472386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redesigning an antibody H3 loop by virtual screening of a small library of human germline-derived sequences.
    Corbeil CR; Manenda MS; Sulea T; Baardsnes J; Picard MÈ; Hogues H; Gaudreault F; Deprez C; Shi R; Purisima EO
    Sci Rep; 2021 Nov; 11(1):21362. PubMed ID: 34725391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.